Immunitor LLC: Clinical Trials

14 trials sponsored by Immunitor LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown, 1 completed. 11 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Unknown 11
Phase 13Unknown 3
Phase 33Unknown 2, Completed 1

Follow Immunitor LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy of Chronic Kidney Failure
V8 - Renal Failure Chronic
Phase 2UnknownImmunitor LLC202020-06-162020-05-08
Tableted COVID-19 Therapeutic Vaccine
V-SARS - Covid19
Phase 1 / Phase 2UnknownImmunitor LLC202020-05-152020-05-27
V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
V-Boost - Glioblastoma Multiforme, Glioma of Brain
Phase 2UnknownImmunitor LLC202019-04-162019-04-17
Open Label Immunotherapy Trial for Breast Cancer
V3-MOMMO - Breast Cancer
Phase 2UnknownImmunitor LLC202018-07-012019-08-30
Open Label Immunotherapy Trial for Ovarian Cancer
Tableted vaccine (V3-OVA) containing ovarian cancer antigens - Ovarian Cancer
Phase 2UnknownImmunitor LLC202018-07-012019-08-30
Immunotherapy of Cervical Cancer With V3-Cervix
V3-Cervix - Cervical Cancer
Phase 2UnknownImmunitor LLC202018-07-012019-08-30
Open Label Immunotherapy of Myoma
V3-Myoma - Myoma;Uterus, Fibroid Uterus
Phase 2UnknownImmunitor LLC302018-06-012018-07-06
Open Label Immunotherapy of Endometriosis
V-Endo - Endometriosis
Phase 2UnknownImmunitor LLC302017-10-012019-04-16
Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer
V3-P - Pancreatic Cancer Non-resectable
Phase 1 / Phase 2UnknownImmunitor LLC302017-05-012019-08-30
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
Oral therapeutic vaccine V3-X to treat cholangiocarcinoma - Cholangiocarcinoma
Phase 1 / Phase 2UnknownImmunitor LLC202017-02-202019-08-30
Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity
atherosclerosis vaccine, Placebo pills - Atherosclerosis
Phase 3UnknownImmunitor LLC3002017-02-012019-04-16
Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L
hepcortespenlisimut-L, Placebo - Hepatocellular Carcinoma, HCC
Phase 3UnknownImmunitor LLC1202015-01-012019-02-26
Open Label Trial of Immunotherapy for Advanced Liver Cancer
Daily oral dose of hepcortespenlisimut-L - HCC, Liver Cirrhosis
Phase 2UnknownImmunitor LLC1202014-09-012019-08-30
TB Immunotherapy Trial With Heat-killed M. Vaccae
V7, Placebo - Tuberculosis
Phase 3CompletedImmunitor LLC1522014-03-012019-07-25

Conditions studied

Cholangiocarcinoma (2)  ·  Atherosclerosis (1)  ·  Autoimmune Diseases (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Carcinoma, Hepatocellular (1)  ·  Coronavirus Infections (1)  ·  Endometriosis (1)  ·  Fibroma (1)  ·  Fibrosis (1)  ·  Glioblastoma (1)  ·  Hepatitis (1)  ·  Infertility (1)  ·  Inflammation (1)

Countries

Mongolia (14)  ·  Canada (1)  ·  Ukraine (1)

Top investigators

Aldar Bourinbaiar, PhD, MD/PhD (4)  ·  Aldar Bourinbayar, MD/PhD (2)  ·  Allen Bain, PhD (2)  ·  Aldar Bourinbaiar, MD/PhD (1)  ·  Aldar Bourinbayar, PhD, MD/PhD (1)

Results publications

PMID 30514514, PMID 31890902